Albert de la Chapelle, professor in the department of cancer biology and genetics at Ohio State University, has received a lifetime achievement award from the Collaborative Group of the Americas on Inherited Colorectal Cancer, which was established to improve understanding of inherited colorectal cancer and the clinical management of affected families, particularly those living in the Americas.
Neil Gallagher joined AbbVie in a newly created role of vice president & head, Global Oncology Development.
Ramin Shiekhattar, a Sylvester Comprehensive Cancer Center genetics researcher, has received a “Pioneer Award” and a five-year $5+ million grant from the NIH.
Anita Mattson, associate professor of chemistry and biochemistry at Worcester Polytechnic Institute, received a $1.7-million award from NIH to develop a new class of catalysts that could make it possible to reliably synthesize organic compounds that hold the promise of treating cancers that have become resistant to commonly used chemotherapy. The catalysts may also open the door to a new approach to discovering drugs for cancer and other diseases.
LUNGevity Foundation announced a parternship with the ALK Positive patient group to support the new ALK-Positive Lung Cancer Transformational Research Award Program.
John DiPersio, of Washington University School of Medicine in St. Louis, received a $6 million outstanding investigator award from NCI to support research aimed at improving therapies for leukemia.
John Hopkins researchers received a $5 million grant from the NCI to unite biologists, clinicians and engineers at the new Johns Hopkins Center for Cancer Target Discovery and Development.
Gad Getz, of the Broad Institute of MIT and Harvard, the Massachusetts General Hospital Cancer Center, and Harvard Medical School; Chuan He of the University of Chicago; and Aviv Regev of the Broad Institute have won the Paul Marks Prize for Cancer Research.xxx:moreThe recipients were announced by
The Children's Neuroblastoma Cancer Foundation announced its support to advance research into a therapeutic strategy for high-risk neuroblastoma.
The Association of Community Cancer Centers presented the David King Community Clinical Scientist Award was presented to the Sanford Health Clinical Research Team from Sioux Falls.
